Corpus Intelligence IC Memo — LARGO MEDICAL CENTER 2026-04-26 09:32 UTC
IC Memo — LARGO MEDICAL CENTER
Investment Committee Memorandum | FL | 245 beds | Grade C | EBITDA uplift $28.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LARGO MEDICAL CENTER

CCN 100248 | PINELLAS, FL | 245 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LARGO MEDICAL CENTER is a 245-bed suburban community hospital in PINELLAS, FL with $386.4M in net patient revenue and a 24.1% operating margin. The hospital serves a payer mix of 25.0% Medicare, 9.1% Medicaid, and 65.9% commercial.

Thesis: Platform Growth. Our ML models identify $28.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 24.1% to 31.5% (+736bps).

Net Revenue HCRIS$386.4M
Current EBITDA COMPUTED$93.1M
Operating Margin COMPUTED24.1%
Occupancy HCRIS76.3%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS9.9%
Distress Probability ML40.9%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
112
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 24.1% places it above the state median. Among 112 size-comparable peers (122-490 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (122-490), prioritizing same-state peers. 112 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LARGO MEDICAL CENTER (Target)FL245$386.4M24.1%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
MEMORIAL HOSPITAL WESTFL486$741.4M5.2%
SOUTH MIAMI HOSPITALFL375$688.4M11.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $28.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.1M+210bp18mo
Cost to Collect4.5%2.5%$7.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.7M+122bp9mo
Clean Claim Rate88.0%96.0%$247K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.1M
Cost to Collect
$7.7M
Denial Rate Reduction
$7.7M
A/R Days Reduction
$4.7M
Clean Claim Rate
$247K
Total EBITDA Uplift$28.4M
Current EBITDA$93.1M
+ RCM Uplift+$28.4M
Pro Forma EBITDA$121.5M
Current Margin24.1%
Pro Forma Margin31.5%
WC Released (1x)$14.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$143.2M$898.4M6.27x44.4%
Base (11x exit)10.0x11.0x$143.2M$1.03B7.23x48.5%
Bull Case9.0x11.0x$128.9M$1.18B9.12x55.6%
Bull (12x exit)9.0x12.0x$128.9M$1.32B10.24x59.2%
Bear Case11.0x10.0x$157.5M$709.7M4.51x35.1%
Bear (11x exit)11.0x11.0x$157.5M$831.8M5.28x39.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 112 hospitals with 122-490 beds
  • Same-state prioritization (n=113)
  • Comp margins: P25=-5.3% / P50=2.8% / P75=16.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.